Latest stem cell news and commentary

Unproven stem cell therapy goes to trial

A controversial and unproven stem cell procedure is to be evaluated in a controlled clinical trial, following a vote in the Italian Senate last week.

The Italian Parliament’s Chamber of Deputies had last Monday voted to amend an earlier controversial decree by Italian Senate, which allowed the unproven stem cell method developed by the Stamina Foundation to be used for severely or terminally ill new patients for 18 months.

Spotlight on clinical research for International Clinical Trials Day

Earlier this month our partner ECRIN celebrated International Clinical Trials Day with an event in Warsaw.

Tips for imaginative science writing

With our stem cell non-fiction writing competition well underway, writer and competition organiser Barbara Melville shares some top tips for creative non-fiction writing. Keep reading for her advice on how to compose a great entry for our imaginative science writing category. And don't forget, whether it's writing, graphic non-fiction or non-fiction poetry that's your thing, the deadline for submissions in all competition categories is 30th June.

Schools pack now available in print

Our All about stem cells activity pack is now available to order in print!

Suitable for use with 16+ year olds, the pack contains a set of activity cards, an activity guide with lesson plan and a question card for students. Read on to find out more about the materials and how to order.




Start as a Stem Cell floor game in action

My name is Marisa Ojala and I am doing my PhD studies at the Institute of Biomedical Technology in the University of Tampere, Finland. Our heart group is lead by Katriina Aalto-Setälä and the aim of our group is to study genetic heart diseases using human induced pluripotent stem cells  – a lab-grown type of stem cell that can make all the different cells of the body. In my project I am focusing on a disease called familial hypertrophic cardiomyopathy (HCM). I recently had the chance to try out EuroStemCell's Start as a Stem Cell game for introducing the public to stem cells and I would like to share my experiences with you.

"Regulation under attack": researchers concerned about unproven stem cell therapies

Leading stem cell experts have published a statement expressing serious concerns about unproven stem cell therapies. Their article, published on 3rd May in The EMBO Journal, sends a strong message to the Italian parliament, which is currently debating whether to change a recent law allowing the use of certain untested stem cell therapies in public hospitals. The group of 12 senior scientists and 1 legal expert argue that 'only rigorous science and rigorous regulation can ensure translation of science into effective therapies.'

Our non-fiction writing competition: FAQ

Have you seen our stem cell non-fiction writing competition? We launched it at the start of April, with a deadline of 30th June. You can enter non-fiction imaginative science writing, graphical work or poetry to be in with the chance to win 300 Euros and publication on

We've had several questions about the details of the competition, so we've decided to publish the answers here. We'll keep adding to these over the coming weeks. If you can't find the answer you're looking for below, please contact Barbara Melville.

Stem Cell Generations!

Our partners at the University of Cambridge have been using tools from our stem cell toolkit as part of their public engagement over recent weeks. Read on to find out more about what the enthusiastic Cambridge researchers have been up to.

Stem cell therapies and neurological disorders of the brain: what is the truth?

There have been several claims that stem cells can already be used in patients affected by neurological disorders. What do we really know about these therapies and how should these claims be viewed?

Making red blood cells: A model of stem cell therapy development

Translating laboratory research into cell therapies raises many complex questions and challenges for both science and society. Social scientist Emma King spent four years following a regenerative medicine research project to examine how clinical translation might work in practice. Here, she reflects on what she learnt and what it might mean for the development of future therapies.

Syndicate content